Form 4: BeiGene Executive Sells Shares
Insider Transaction (Form 4)
Chan Henry Lee, SVP, General Counsel of BeiGene, Ltd., sold 1,669 shares of common stock on July 22, 2026 for $325.00 per share.
Summary
- Option exercise/conversion: acquired 514 American Depositary Shares at $194.47 ($99,958) on July 22, 2026; holds 514 after (Direct).
- Option exercise/conversion: acquired 665 American Depositary Shares at $213.32 ($141,858) on July 22, 2026; holds 1,179 after (Direct).
- Option exercise/conversion: acquired 490 American Depositary Shares at $159.03 ($77,925) on July 22, 2026; holds 1,669 after (Direct).
- Open-market sale: disposed of 1,669 American Depositary Shares at $325.00 ($542,425) on July 22, 2026 (Direct).
- Option exercise/conversion: disposed of 6,682 Share Option (Right to Buy) on July 22, 2026; holds 10,556 after (Direct).
- Option exercise/conversion: disposed of 8,645 Share Option (Right to Buy) on July 22, 2026; holds 71,123 after (Direct).
- Option exercise/conversion: disposed of 6,370 Share Option (Right to Buy) on July 22, 2026; holds 98,930 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $542,425 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Chan Henry Lee — Officer (SVP, General Counsel)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-22 | Option exercise/conversion | American Depositary Shares | 514 | $194 | $100.0K | 514 |
| 2026-07-22 | Option exercise/conversion | American Depositary Shares | 665 | $213 | $141.9K | 1,179 |
| 2026-07-22 | Option exercise/conversion | American Depositary Shares | 490 | $159 | $77.9K | 1,669 |
| 2026-07-22 | Open-market sale | American Depositary Shares | 1,669 | $325 | $542.4K | 0 |
| 2026-07-22 | Option exercise/conversion | Share Option (Right to Buy) | 6,682 | — | — | 10,556 |
| 2026-07-22 | Option exercise/conversion | Share Option (Right to Buy) | 8,645 | — | — | 71,123 |
| 2026-07-22 | Option exercise/conversion | Share Option (Right to Buy) | 6,370 | — | — | 98,930 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-22 | Option exercise/conversion (514 shares) |
| 2026-07-22 | Option exercise/conversion (665 shares) |
| 2026-07-22 | Option exercise/conversion (490 shares) |
| 2026-07-22 | Open-market sale (1,669 shares) |
| 2026-07-22 | Option exercise/conversion (6,682 shares) |
| 2026-07-22 | Option exercise/conversion (8,645 shares) |
| 2026-07-22 | Option exercise/conversion (6,370 shares) |
Keywords
insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, Chan Henry Lee
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.